NIH Weekly Funding Opportunities and Policy Notices

Notice of Special Interest (NOSI) Announcing the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus
Thursday, April 15, 2021 - 6:56am
Notice NOT-DA-21-041 from the NIH Guide for Grants and Contracts
Continuation of Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During the COVID-19 Pandemic
Thursday, April 15, 2021 - 12:01am
Notice NOT-OD-21-106 from the NIH Guide for Grants and Contracts
Notice of Special Interest (NOSI): Administrative Supplement for Modifiable Factors Potentially affecting the Cost of Cancer Treatment
Wednesday, April 14, 2021 - 10:59am
Notice NOT-CA-21-055 from the NIH Guide for Grants and Contracts
Notice of Special Interest (NOSI): Telehealth in Cancer Care
Wednesday, April 14, 2021 - 10:53am
Notice NOT-CA-21-043 from the NIH Guide for Grants and Contracts
NIMHD Multiple Chronic Disease Disparities Research Coordinating Center (RCC) (U24 Clinical Trial Not Allowed)
Wednesday, April 14, 2021 - 10:37am
Funding Opportunity RFA-MD-21-008 from the NIH Guide for Grants and Contracts. NIMHD invites applications from eligible institutions to establish a Research Coordinating Center (RCC) to support comprehensive research centers on prevention, treatment, and management of co-occurring chronic diseases associated with health disparities. The RCC will coordinate activities across all of the chronic disease centers, including data collection; promoting collaboration and communication among investigators and the broader research community; promoting skills development of early stage investigators; coordinating and managing in-person and/or virtual meetings; and facilitating community engagement efforts.
Centers for Multiple Chronic Diseases Associated with Health Disparities: Prevention, Treatment, and Management (P50 Clinical Trial Required)
Wednesday, April 14, 2021 - 10:37am
Funding Opportunity RFA-MD-21-007 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to support comprehensive research centers on prevention, treatment, and management of multiple chronic diseases associated with associated with health disparities.
Notice of Change: Receipt date added for RFA-EB-20-002, "BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
Wednesday, April 14, 2021 - 10:19am
Notice NOT-EB-21-006 from the NIH Guide for Grants and Contracts
Reminder: Required use of FORMS-F application forms for application submission
Wednesday, April 14, 2021 - 9:55am
Notice NOT-OD-21-104 from the NIH Guide for Grants and Contracts
Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Developmental Project (UH2 Clinical Trial Optional)
Wednesday, April 14, 2021 - 9:18am
Notice NOT-AA-21-024 from the NIH Guide for Grants and Contracts
Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Data Coordination Core (U24 Clinical Trial Not Allowed)
Wednesday, April 14, 2021 - 9:18am
Notice NOT-AA-21-023 from the NIH Guide for Grants and Contracts
Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Diagnostic-Telemedicine Core (U24 Clinical Trial Not Allowed)
Wednesday, April 14, 2021 - 9:18am
Notice NOT-AA-21-022 from the NIH Guide for Grants and Contracts
Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Administrative Core (U24) (Clinical Trial Not Allowed)
Wednesday, April 14, 2021 - 9:18am
Notice NOT-AA-21-021 from the NIH Guide for Grants and Contracts
Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Project (U01 Clinical Trial optional)
Wednesday, April 14, 2021 - 9:18am
Notice NOT-AA-21-020 from the NIH Guide for Grants and Contracts
Notice of NIAAA Participation in NOT-OD-21-086 "Notice of Intent to Reissue PAR-18-324 "Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)" as a Notice of Special Interest (NOSI)"
Wednesday, April 14, 2021 - 8:07am
Notice NOT-AA-21-015 from the NIH Guide for Grants and Contracts
3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed)
Wednesday, April 14, 2021 - 12:15am
Funding Opportunity RFA-CA-21-037 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) as a part of its Beau Biden Cancer Moonshot Initiative invites submission of applications requesting support for projects that will accelerate cancer research. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP) as Recommendation I: Generation of Human Tumor Atlases. The overarching goal of this FOA is to accelerate research efforts conducted and led by the Human Tumor Atlas Network (HTAN, humantumoratlas.org) via the implementation of three-dimensional (3D) imaging technologies that will allow for a comprehensive view of the dynamic multidimensional ecosystems that define tumors in humans. Each project will lead to the multiplexed 3D characterization of at least one cancer transition investigated by the HTAN (pre-malignant to malignant, primary to metastatic, therapy responsive to resistant). The data and analytical tools generated through this FOA will be made available for use by the research and clinical communities through the activities of the HTAN Data Coordinating Center.
Notice of Change: Extension and Additional Key Dates for NIAAA RFA-AA-21-004 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed)"
Wednesday, April 14, 2021 - 12:01am
Notice NOT-AA-21-027 from the NIH Guide for Grants and Contracts
Notice of Change: Extension and Additional Key Dates for NIAAA RFA-AA-21-003 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed)"
Tuesday, April 13, 2021 - 11:53pm
Notice NOT-AA-21-026 from the NIH Guide for Grants and Contracts
Notice of Change: Extension and Additional Key Dates for NIAAA RFA-AA-21-002 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed)"
Tuesday, April 13, 2021 - 11:43pm
Notice NOT-AA-21-025 from the NIH Guide for Grants and Contracts
Notice of Special Interest (NOSI): Topic Areas for PAR-21-203, Limited Competition: Clinical and Translational Science Award (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Not Allowed)
Tuesday, April 13, 2021 - 11:12pm
Notice NOT-TR-21-025 from the NIH Guide for Grants and Contracts
Updated NCI Guidance Concerning the Mentored Clinical Scientist Research Career Development Award: Percent Effort of Surgeon-Scientists for K08 awards from NCI
Tuesday, April 13, 2021 - 10:58am
Notice NOT-CA-21-054 from the NIH Guide for Grants and Contracts

Pages